CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Dexcom glucose sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05714761
NCT05714761N/ACompleted

Postpartum Dysglycemia Screening With Continuous Glucose Monitoring

Icahn School of Medicine at Mount Sinai·interventional·Posted Feb 6, 2023·Updated Mar 20, 2025

In Brief

A clinical study evaluating Dexcom glucose sensor for Gestational Diabetes. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This research study is being done to assess if using a glucose sensor (also known as a continuous glucose monitor) after childbirth can help identify women who are at risk of developing diabetes after having diabetes during pregnancy or gestational diabetes. Currently, screening for diabetes after childbirth is performed with an oral glucose tolerance test 6-12 weeks after delivery, but this is burdensome. This study will use a glucose sensor worn on the skin for 10 days. The data from the sensor will be compared to the standard oral glucose tolerance test. This is a single site study at the Icahn School of Medicine at Mount Sinai. The research team plans to enroll 50 participants aged 18years or older into the study. Participation in the study is expected to last up to 20 weeks and involves 4-5 visits depending on if enrollment is in the 3rd trimester of pregnancy or immediate postpartum. Study procedures include 1. Consent \& screening. 2.Sensor placement and download after 10 days of wear. 3. a second sensor placement 2-5 days before oral glucose tolerance test (OGTT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 6, 2023
Enrollment StartFeb 16, 2023
Primary CompletionMar 8, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.4 years ago

Interventions

Dexcom glucose sensordevice

Use of a Dexcom G6 Pro